An inhibitor of thrombin activated fibrinolysis inhibitor (TAFI) can reduce extracellular matrix accumulation in an in vitro model of glucose induced ECM expansion-Reference-Cited by-同舟云学术

An inhibitor of thrombin activated fibrinolysis inhibitor (TAFI) can reduce extracellular matrix accumulation in an in vitro model of glucose induced ECM expansion

Published:2013-06 Issue:5 Volume:32 Page:277-287
ISSN:0945-053X
Container-title:Matrix Biology
language:en
Short-container-title:Matrix Biology

Author:

Atkinson J.M.,Pullen N.,Johnson T.S.

Funder

BBSRC

Pfizer

Publisher

Elsevier BV

Subject

Molecular Biology

Reference41 articles.

1. High glucose causes an increase in extracellular matrix proteins in cultured mesangial cells;Ayo;Am. J. Pathol.,1990

2. Purification and characterization of TAFI, a thrombin-activable fibrinolysis inhibitor;Bajzar;J. Biol. Chem.,1995

3. TAFI, or plasma procarboxypeptidase B, couples the coagulation and fibrinolytic cascades through the thrombin–thrombomodulin complex;Bajzar;J. Biol. Chem.,1996

4. Extracellular matrix degradation and the role of hepatic stellate cells;Benyon;Semin. Liver Dis.,2001

5. Protective role of thrombin activatable fibrinolysis inhibitor in obstructive nephropathy-associated tubulointerstitial fibrosis;Bruno;J. Thromb. Haemost.,2008

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Purine adducts as a presumable missing link for aristolochic acid nephropathy‐related cellular energy crisis, potential anti‐fibrotic prevention and treatment;British Journal of Pharmacology;2021-08-09

2. Carboxypeptidase U (CPU, TAFIa, CPB2) in Thromboembolic Disease: What Do We Know Three Decades after Its Discovery?;International Journal of Molecular Sciences;2021-01-17

3. ECM Characterization Reveals a Massive Activation of Acute Phase Response during FSGS;International Journal of Molecular Sciences;2020-03-18

4. Pathophysiological significance of protein hydrophobic interactions: An emerging hypothesis;Medical Hypotheses;2018-01

5. Activated thrombin-activatable fibrinolysis inhibitor attenuates the angiogenic potential of endothelial cells: potential relevance to the breast tumour microenvironment;Clinical & Experimental Metastasis;2017-01-25